Bilateral Retromuscular Rectus Sheath Block Catheters Usage for Early Postoperative Analgesia After Laparotomic Gastrectomy.

Sponsor
Riga East Clinical University Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05592496
Collaborator
University of Latvia (Other)
100
2
2
37
50
1.4

Study Details

Study Description

Brief Summary

In early postoperative period, the occurrence of severe pain after open major upper GI surgery is a significant issue. The study is aimed to access the efficiency of rectus sheet block with continuous bupivacaine infusion catheters into retromuscular space in providing an effective pain relief, decreasing opioid consumption and enhancing postoperative recovery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Bilateral retromuscular rectus sheath block catheters usage for early postoperative analgesia after laparotomic gastrectomy.
  • Device: Catheter insertion technique by using special tube t
  • Procedure: Connection of catheters bilateraly to "easy pump" system,
  • Diagnostic Test: VAS scale for pain control
N/A

Detailed Description

This prospective randomised case-control experimental study is being conducted in Riga East University Hospital (Latvia). Patients with total or subtotal open gastrectomy were divided into two groups - half patients in the Block group and half patients in the Control group. In the Block group and control group, retromuscular catheters in the m. rectus abdominis sheath is going to be placed before fascia closure. Catheters will be placed under the direct supervision of a surgeon throughout the operation wound on both sides of the incision.

After surgery patients in the Block group will receive continuous 0.125% (10-12 mg/h) bupivacaine infusion through rectus sheath catheters for 72 h. Additionaly ketorolac or trimeperidine infusion will be performed if VAS of pains more than 30mm. If pains continue, additional opioids will be performed.

Patients in the Control group received 0,9% NaCl solution 72 hours by using the same "easy pump" system, and ketorolac or trimeperidine injection if necessery Pain intensity will be assessed in both groups using 0-100 mm Visual Analog Scale (VAS) at 24, 48 and 72 hour intervals after surgery at rest and during movement (by asking the patient to bend legs). Postoperative complications, hospital stay, comorbidities, the time taken to start walking after the surgery, bowel movements (time until first stool) were all examined.

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Bilateral Retromuscular Rectus Sheath Block Catheters Usage for Early Postoperative Analgesia After Laparotomic Gastrectomy.
Actual Study Start Date :
Jan 1, 2021
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Jan 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Block group

Patients after laparotomic gastrectomy and musculus rectus sheath block and continuous analgesia with 0,125% bupivacaine solution for 72h

Procedure: Bilateral retromuscular rectus sheath block catheters usage for early postoperative analgesia after laparotomic gastrectomy.
After surgery patients in the Block group receives continuous 0.125% (10-12 mg/h) bupivacaine infusion through rectus sheath catheters for 72 h in addition to fentanyl i/v infusion on postoperative day 0, and ketorolac or trimeperidine injection on postoperative day 1-2 if necessery. Patients in the Control group receives NaCl 0,9% infusion and fentanyl i/v infusion on postoperative day 0 and ketorolac or trimeperidine injection on postoperative day 1-2 if necessery Pain intensity is going to be assessed in both groups using 0-100 mm Visual Analog Scale (VAS) at 24, 48 and 72 hour intervals after surgery at rest and during movement (by asking the patient to bend legs). Postoperative complications, hospital stay, comorbidities, the time taken to start walking after the surgery, bowel movements (time until first stool) were all examined.
Other Names:
  • Catheter insertion technique by using special tube to positionate it in retromuscular space
  • Device: Catheter insertion technique by using special tube t
    By using special tube, it is possible to locate the catheters in retromuscular space, where they are close to cutaneous nervs

    Procedure: Connection of catheters bilateraly to "easy pump" system,
    Connection of catheters, which are inserted in to retromuscular space, to ensure continuous receiving of Bupivacaine fluid for analgesia. "Easy pump" system provides continous receiving of bupivacaine fluid infusion speed - 5ml per hour

    Diagnostic Test: VAS scale for pain control
    By using Visual Analog scale of pains, the pain score is fixed

    Placebo Comparator: Control group

    Patients after laparotomic gastrectomy, musculus rectus sheath block and induction of 0,9% NaCl Solution by using "easy pump" system for 72 h

    Procedure: Bilateral retromuscular rectus sheath block catheters usage for early postoperative analgesia after laparotomic gastrectomy.
    After surgery patients in the Block group receives continuous 0.125% (10-12 mg/h) bupivacaine infusion through rectus sheath catheters for 72 h in addition to fentanyl i/v infusion on postoperative day 0, and ketorolac or trimeperidine injection on postoperative day 1-2 if necessery. Patients in the Control group receives NaCl 0,9% infusion and fentanyl i/v infusion on postoperative day 0 and ketorolac or trimeperidine injection on postoperative day 1-2 if necessery Pain intensity is going to be assessed in both groups using 0-100 mm Visual Analog Scale (VAS) at 24, 48 and 72 hour intervals after surgery at rest and during movement (by asking the patient to bend legs). Postoperative complications, hospital stay, comorbidities, the time taken to start walking after the surgery, bowel movements (time until first stool) were all examined.
    Other Names:
  • Catheter insertion technique by using special tube to positionate it in retromuscular space
  • Device: Catheter insertion technique by using special tube t
    By using special tube, it is possible to locate the catheters in retromuscular space, where they are close to cutaneous nervs

    Procedure: Connection of catheters bilateraly to "easy pump" system,
    Connection of catheters, which are inserted in to retromuscular space, to ensure continuous receiving of Bupivacaine fluid for analgesia. "Easy pump" system provides continous receiving of bupivacaine fluid infusion speed - 5ml per hour

    Diagnostic Test: VAS scale for pain control
    By using Visual Analog scale of pains, the pain score is fixed

    Outcome Measures

    Primary Outcome Measures

    1. Pain scores [3 days]

      Patients will be asked to score their pain in recovery and on days 0,1,2,3 post surgery

    2. Opioid usage after surgery [3 days]

      If the VAS of pains is more than 30mm, after receiving NSAIDs, opioid solution will be performed

    Secondary Outcome Measures

    1. Peri-operative analgesic use [4 days]

      Analgesic use intra-operatively and post-operatively for 3 days. This will include strong opioids, paracetamol, NSAIDs, codeine, ketamine, IV lignocaine, tramadol, clonidine and PCA usage post-operatively.

    2. TIme to diet and mobilisation [likely 5 days]

      Time to first defecation

    3. Time to discharge [approximately 7 days]

      how many days after Surgery

    4. Postoperative complications [approximately 14 days]

      all postoperative complications (Clavien Dindo classification)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Open Laparotomy and gastrectomy
    Exclusion Criteria:
    • acute surgery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Igors Ivanovs Riga Latvia LV1038
    2 Riga East Clinical University hospital Riga Latvia LV1038

    Sponsors and Collaborators

    • Riga East Clinical University Hospital
    • University of Latvia

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Riga East Clinical University Hospital
    ClinicalTrials.gov Identifier:
    NCT05592496
    Other Study ID Numbers:
    • 001
    First Posted:
    Oct 24, 2022
    Last Update Posted:
    Oct 24, 2022
    Last Verified:
    Oct 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 24, 2022